JP2013536865A5 - - Google Patents

Download PDF

Info

Publication number
JP2013536865A5
JP2013536865A5 JP2013527294A JP2013527294A JP2013536865A5 JP 2013536865 A5 JP2013536865 A5 JP 2013536865A5 JP 2013527294 A JP2013527294 A JP 2013527294A JP 2013527294 A JP2013527294 A JP 2013527294A JP 2013536865 A5 JP2013536865 A5 JP 2013536865A5
Authority
JP
Japan
Prior art keywords
propyl
methyl
hexadecyloxy
degrees
mono
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013527294A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013536865A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/050099 external-priority patent/WO2012031045A2/en
Publication of JP2013536865A publication Critical patent/JP2013536865A/ja
Publication of JP2013536865A5 publication Critical patent/JP2013536865A5/ja
Pending legal-status Critical Current

Links

JP2013527294A 2010-08-31 2011-08-31 ホスホン酸エステル誘導体およびその合成方法 Pending JP2013536865A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US37874310P 2010-08-31 2010-08-31
US61/378,743 2010-08-31
PCT/US2011/050099 WO2012031045A2 (en) 2010-08-31 2011-08-31 Phosphonate ester derivatives and methods of synthesis thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015196930A Division JP2016094388A (ja) 2010-08-31 2015-10-02 ホスホン酸エステル誘導体およびその合成方法

Publications (2)

Publication Number Publication Date
JP2013536865A JP2013536865A (ja) 2013-09-26
JP2013536865A5 true JP2013536865A5 (https=) 2015-08-06

Family

ID=45771142

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2013527294A Pending JP2013536865A (ja) 2010-08-31 2011-08-31 ホスホン酸エステル誘導体およびその合成方法
JP2015196930A Pending JP2016094388A (ja) 2010-08-31 2015-10-02 ホスホン酸エステル誘導体およびその合成方法
JP2017110073A Pending JP2017214378A (ja) 2010-08-31 2017-06-02 ホスホン酸エステル誘導体およびその合成方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2015196930A Pending JP2016094388A (ja) 2010-08-31 2015-10-02 ホスホン酸エステル誘導体およびその合成方法
JP2017110073A Pending JP2017214378A (ja) 2010-08-31 2017-06-02 ホスホン酸エステル誘導体およびその合成方法

Country Status (11)

Country Link
US (3) US8569321B2 (https=)
EP (2) EP3020720B1 (https=)
JP (3) JP2013536865A (https=)
CN (3) CN105218580A (https=)
AU (1) AU2011295937B2 (https=)
BR (1) BR112013004925B1 (https=)
CA (1) CA2809679C (https=)
ES (2) ES2604137T3 (https=)
IL (4) IL224955A (https=)
RU (2) RU2015141024A (https=)
WO (1) WO2012031045A2 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2604137T3 (es) * 2010-08-31 2017-03-03 Chimerix, Inc. Derivados de éster de fosfonato y métodos de síntesis de los mismos
EA201892769A3 (ru) 2013-03-15 2019-08-30 Дзе Риджентс Оф Дзе Юниверсити Оф Калифорния Сложные диэфиры ациклических нуклеозидфосфонатов
DK2999476T3 (en) 2013-11-15 2018-09-03 Chimerix Inc MORPHIC FORMS OF HEXADECYLOXYPROPYL PHOSPHONATE TESTERS
WO2015085256A1 (en) * 2013-12-05 2015-06-11 Chimerix, Inc. Branched chain acyclic nucleoside phosphonate esters and methods of synthesis and uses thereof
CN103951703A (zh) * 2014-04-28 2014-07-30 中国人民解放军军事医学科学院微生物流行病研究所 制备膦酯衍生物的方法
BR112017005111B1 (pt) 2014-09-15 2023-02-14 The Regents Of The University Of California Compostos análogos de nucleotídeo acíclico, composição farmacêutica contendo tais compostos, e usos da composição no tratamento de uma infecção por papilomavírus
EP3212656B1 (en) 2014-10-27 2019-06-05 Concert Pharmaceuticals Inc. Pyrimidine phosphonic acid esters bearing at least one deuterium atom
WO2017048956A1 (en) 2015-09-15 2017-03-23 The Regents Of The University Of California Nucleotide analogs
EP4295853A3 (en) 2016-06-28 2024-03-06 Emergent BioDefense Operations Lansing LLC Formulations of brincidofovir
CA3105038A1 (en) 2018-06-26 2020-01-02 Tsrl, Inc. Metabolically stable prodrugs
CN109021011A (zh) * 2018-08-14 2018-12-18 山东沾化永浩医药科技有限公司 一种合成对甲苯磺酰氧甲基膦酸二乙酯的方法
IL318465A (en) 2022-07-21 2025-03-01 Antiva Biosciences Inc Compositions and dosage forms for the treatment of HPV infection and HPV-induced neoplasia

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
FI930552A7 (fi) * 1990-08-10 1993-02-22 Rega Stichting Uusi menetelmä nukleotidien valmistamiseksi
EP1123308A1 (en) * 1998-10-23 2001-08-16 Darwin Discovery Limited Single morphic forms of known peptide metalloproteinase inhibitors
DE60038038T2 (de) 1999-12-03 2009-02-12 The Regents of The University of California at San Diego, La Jolla Phosphonatverbindungen
DE602004031115D1 (de) * 2003-06-16 2011-03-03 Acad Of Science Czech Republic Pyrimidinverbindungen mit phosphonatgruppen als antivirale nucleotidanaloga
JP2005045073A (ja) 2003-07-23 2005-02-17 Hamamatsu Photonics Kk 裏面入射型光検出素子
WO2005090370A1 (en) * 2004-02-05 2005-09-29 The Regents Of The University Of California Pharmacologically active agents containing esterified phosphonates and methods for use thereof
WO2005087788A2 (en) * 2004-03-04 2005-09-22 The Regents Of The University Of California Methods for preparation of nucleoside phosphonate esters
WO2006066074A2 (en) * 2004-12-16 2006-06-22 The Regents Of The University Of California Lung-targeted drugs
JP2008535862A (ja) 2005-04-08 2008-09-04 キメリクス,インコーポレイテッド ポックスウイルス感染の治療のための化合物、組成物および方法
JP2008538354A (ja) 2005-04-08 2008-10-23 キメリクス,インコーポレイテッド ウイルス感染症およびその他の内科疾患を治療するための化合物、組成物および方法
ES2600792T3 (es) * 2006-05-03 2017-02-10 Chimerix, Inc. Alcoxialquilésteres metabólicamente estables de fosfonatos, fosfonatos nucleosídicos y fosfatos nucleosídicos antivirales o antiproliferativos
WO2008133966A1 (en) * 2007-04-27 2008-11-06 Chimerix, Inc. Methods of reducing nephrotoxicity in subjects administered with nucleoside
US8614200B2 (en) * 2009-07-21 2013-12-24 Chimerix, Inc. Compounds, compositions and methods for treating ocular conditions
WO2011017253A1 (en) 2009-08-03 2011-02-10 Chimerix, Inc. Composition and methods of treating viral infections and viral induced tumors
WO2011053812A1 (en) 2009-10-30 2011-05-05 Chimerix, Inc. Methods of treating viral associated diseases
US20110263536A1 (en) 2010-04-22 2011-10-27 Chimerix, Inc. Methods of Treating Orthopox Virus Infections and Associated Diseases
ES2604137T3 (es) * 2010-08-31 2017-03-03 Chimerix, Inc. Derivados de éster de fosfonato y métodos de síntesis de los mismos
WO2013063436A1 (en) * 2011-10-26 2013-05-02 Chimerix, Inc. Hexadecyloxypropyl cidofovir for the treatment of double-stranded dna virus infection
WO2013163509A1 (en) * 2012-04-27 2013-10-31 Chimerix, Inc. A method of mitigating virus associated end-organ damage
DK2999476T3 (en) * 2013-11-15 2018-09-03 Chimerix Inc MORPHIC FORMS OF HEXADECYLOXYPROPYL PHOSPHONATE TESTERS

Similar Documents

Publication Publication Date Title
JP2013536865A5 (https=)
AU2016271126B2 (en) Tetrasubstituted alkene compounds and their use
CA1339780C (en) Antiviral phosphonomethoxyalkylene purine and pyrimidine derivatives
CN101218210B (zh) 罗苏伐他汀的制备方法和中间体
TWI642677B (zh) 非環狀核苷膦酸二酯
RU2013114370A (ru) Производные эфиров фосфоновых кислот и способы их синтеза
CN102295660A (zh) 泰诺福韦的合成工艺
CN104817593B (zh) 半富马酸替诺福韦艾拉酚胺关键中间体的合成工艺
CN112175003B (zh) 一种苯基氢膦酸酯及其中间体的制备方法
TW201623323A (zh) 替諾福韋前藥新多晶型及其製備方法和用途
WO2010086438A1 (en) Key intermediates for the synthesis of rosuvastatin or pharmaceutically acceptable salts thereof
JP2012523444A (ja) 内皮受容体アンタゴニスト(ボセンタン)を調製するための方法
CN102453055B (zh) 制备(r)-9-(2-膦酰甲氧基丙基)腺嘌呤双(异丙氧羰基氧甲基)酯的方法
KR101832238B1 (ko) 신규한 설포닐옥시메틸포스포네이트 유도체 및 이를 이용한 다이아이소프로필 ((1-(트리틸옥시메틸)-사이클로프로필)옥시)메틸 포스포네이트의 제조방법
EP2800735B1 (en) Process for the preparation of fesoterodine
WO2015131405A1 (zh) 用于制备瑞舒伐他汀钙的中间体化合物以及由其制备瑞舒伐他汀钙的方法
JP2017503020A (ja) Hx塩の形態の(e)−4−n,n−ジアルキルアミノクロトン酸の製造方法、およびegfrチロシンキナーゼ阻害剤の合成のためのその使用
CN106674281A (zh) 一种瑞舒伐他汀中间体化合物、制备方法及其用途
KR101195631B1 (ko) 9-[2-(포스포노메톡시)에틸]아데닌의 개선된 제조방법
WO2024249672A1 (en) Process of preparing hiv capsid inhibitor
RU2007104036A (ru) Способ получения диизопропил (гидроксиметил)-циклопропил)окси) метилфосфоната
JPH0273072A (ja) ヒドロキシメチルシクロブチルプリン類
CN116063233A (zh) 一种1h-咪唑-1-乙酸烃酯的制备方法
WO2015003589A1 (zh) 替诺福韦及其中间体的制备方法
CN105254670A (zh) (r)-9-[2-(磷酸甲氧基)丙基]腺嘌呤的制备方法